377 related articles for article (PubMed ID: 16299452)
1. Finasteride and minoxidil for alopecia revisited.
Med Lett Drugs Ther; 2005 Nov; 47(1222):95-6. PubMed ID: 16299452
[No Abstract] [Full Text] [Related]
2. Propecia and Rogaine Extra Strength for alopecia.
Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
[No Abstract] [Full Text] [Related]
3. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
Saraswat A; Kumar B
Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
[No Abstract] [Full Text] [Related]
4. Direct-to-consumer advertising. Finasteride for male pattern hair loss.
Cassels A; Wright JM; Mintzes B; Jauca C
Can Fam Physician; 2001 Sep; 47():1751-5. PubMed ID: 11570300
[No Abstract] [Full Text] [Related]
5. Human genetics. Hair apparent.
Davies K
Nature; 1998 Feb; 391(6667):537, 539. PubMed ID: 9468131
[No Abstract] [Full Text] [Related]
6. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Walsh DS; Dunn CL; James WD
Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
[No Abstract] [Full Text] [Related]
7. Finasteride revisited: Proscar for the prostate and Propecia for the pate.
Harv Mens Health Watch; 2000 Jul; 4(12):1-4. PubMed ID: 10877872
[No Abstract] [Full Text] [Related]
8. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Tosti A; Iorizzo M; Vincenzi C
Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
[No Abstract] [Full Text] [Related]
9. Hair loss.
Patel JC
Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
[No Abstract] [Full Text] [Related]
10. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
11. [Androgenetic alopecia. Denser hair growth on two-thirds of balding scalps].
MMW Fortschr Med; 2000 May; 142(20):63. PubMed ID: 10870400
[No Abstract] [Full Text] [Related]
12. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of female androgenic alopecia with dutasteride.
Olszewska M; Rudnicka L
J Drugs Dermatol; 2005; 4(5):637-40. PubMed ID: 16167423
[TBL] [Abstract][Full Text] [Related]
14. Androgenetic alopecia in men: the scale of the problem and prospects for treatment.
Rushton DH
Int J Clin Pract; 1999; 53(1):50-3. PubMed ID: 10344067
[TBL] [Abstract][Full Text] [Related]
15. [Androgenetic alopecia].
Esteve E; Aubin F
Ann Dermatol Venereol; 1997; 124(1):7-11. PubMed ID: 9686040
[No Abstract] [Full Text] [Related]
16. Androgenetic alopecia: overview.
Sawaya ME
J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S14-20. PubMed ID: 11749885
[No Abstract] [Full Text] [Related]
17. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
18. [Androgenetic alopecia: drug treatment].
Granel F
Ann Dermatol Venereol; 2000 Jun; 127 Suppl 1():1S16-20. PubMed ID: 10962364
[No Abstract] [Full Text] [Related]
19. Guidelines for the management of androgenetic alopecia (2010).
Tsuboi R; Itami S; Inui S; Ueki R; Katsuoka K; Kurata S; Kono T; Saito N; Manabe M; Yamazaki M;
J Dermatol; 2012 Feb; 39(2):113-20. PubMed ID: 22171995
[No Abstract] [Full Text] [Related]
20. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
